Domov › CHOPN › South Carolina
Klinické štúdie CHOPN v štáte South Carolina
14 štúdií pre CHOPN hľadá účastníkov v zariadeniach v štáte South Carolina.
Mestá v štáte South Carolina
Oficiálny text štúdie (anglicky)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Anderson
- Research Site, Charleston
- Research Site, Gaffney
- a 2 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- MedTrial- Site Number : 8400010, Columbia
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Clinical Research of Rock Hill, Rock Hill
Prebieha náborFáza 2
Vek 40 až 85 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- AnMed Oglesby Center- Site Number : 8400074, Anderson
- MD First Research - Lancaster- Site Number : 8400102, Lancaster
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Lancaster
- Research Site, Spartanburg
Prebieha náborFáza 2
Vek 40 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Anderson
- Research Site, Columbia
- Research Site, Gaffney
- a 2 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Rock Hill
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Bogan Sleep Consultants, LLC, Columbia
- Velocity Clinical Research, Gaffney, Gaffney
- Clinical Research of Rock Hill, Rock Hill
- a 1 ďalších
Prebieha náborFáza 2/3
Vek 35 až 80 · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 101, Charleston
Prebieha náborFáza 3
Vek 18 až 80 · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT07555483STRIVE Post-Market Registry Study
- AnMed Health, Anderson
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Greenville
- GSK Investigational Site, Rock Hill
Prebieha náborFáza 3
Vek 40 až 75 · Všetky pohlavia · Aktualizované 28. 7. 2026 · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Spartanburg
- GSK Investigational Site, Union
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 9. 4. 2026 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Rock Hill
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 8. 10. 2025 · NCT06959095Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Medical University of South Carolina (MUSC), Charleston
- McLeod Health, Florence
Prebieha náborObservačná štúdia
Vek 50 a viac · Všetky pohlavia · Aktualizované 5. 8. 2025 · NCT06122077Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.